We appreciate this opportunity to defend the concepts we expressed in 2000, in Sacred Cows and Golden Geese: The Human Cost of Experiments on Animals. Enthusiastic critiques such as Dr Michael Festing's are extremely valuable, if those within and without the field of science are finally to understand, choose among, and embrace viable research modalities that are meant to result in cures and treatments for human disease. Criticisms also help to clarify misunderstandings. We hope this essay will shed light on the debate.
FestingM. (2001). Sacred cows and golden geese. ATLA29, 617–619.
2.
GreekC.R., & GreekJ.S. (2000). Sacred Cows and Golden Geese: The Human Cost of Experiments on Animals, 256 pp. New York, USA and London, UK: Continuum International.
3.
HoenigL.J. (1986). Triumph and controversy. Pasteur's preventive treatment of rabies as reported in JAMA. Archives of Neurology43, 397–399.
4.
PasteurL.Oeuvres, VI, 335, 345–347, 605–606, 634, 652–658, 769, 808–813, 841–844, 856. See also, Geison, G.L. (1978). Pasteur's work on rabies: reexamining the ethical issues, Hastings Center Report, April, 26–32.
5.
PasteurL.Oeuvres, VI, 335, 345–347, 605–606, 634, 652–658, 769, 808–813, 841–844, 856. See also, Geison, G.L. (1978). Pasteur's work on rabies: reexamining the ethical issues, Hastings Center Report, April, 26–32, and Science, New York259, 1117, 1993; and Memorandum on Rabies, DHSS, 1977. London, UK: HMSO.
6.
AltmanL.K. (1998). Who Goes First? The Story of Self–Experimentation in Medicine, p. 113. University of California Press; and Dubos, R.J. (1976). Louis Pasteur. Free Lance of Science, pp. 347–348. New York, USA: Scribner's.
7.
PasteurL.Oeuvres, VI, 630–631. See also, Geison, G.L. (1978). Pasteur's work on rabies: reexamining the ethical issues. Hastings Center Report, April, 26–32.
8.
JAMA1887, 9, 119–121.
9.
JAMA1889, 12, 690–692.
10.
PasteurL.Oeuvres, VI, 619. See also, Geison, G.L. (1978). Pasteur's work on rabies: reexamining the ethical issues. Hastings Center Report, April, 26–32.
11.
PasteurL.Oeuvres, VI, 591. See also, Geison, G.L. (1978). Pasteur's work on rabies: reexamining the ethical issues. Hastings Center Report, April, 26–32.
12.
GreekC.R., & GreekJ.S. (2000). Sacred Cows and Golden Geese: the Human Cost of Experiments on Animals, p. 48. New York, USA and London, UK: Continuum International.
13.
FloreyH.W., & ChainE.B. (1949). Antibiotics, Vol. 2, Oxford, UK: Oxford University Press; and Henderson, J.W. (1997). The yellow brick road to penicillin: a story of serendipity. Mayo Clinic Proceedings72, 683–687.
14.
ParkeD.V. (1994). Clinical pharmacokinetics in drug safety evaluation. ATLA22, 207–209.
15.
KoppanyiT., & AveryM.A. (1966). Species differences and the clinical trial of new drugs: a review. Clinical Pharmacology and Therapeutics7, 250–270.
16.
AllisonV.D. (1974). Personal recollections of Sir Almroth Wright and Sir Alexander Fleming. The Ulster Medical Journal43, 89–98.
17.
WeisseA.B. (1991). The long pause. The discovery and rediscovery of penicillin. Hospital Practice (Off Ed) 26, 93–96, 101–104, 107 passim.
18.
SteffeeC.H. (1992). Alexander Fleming and penicillin. The chance of a lifetime?North Carolina Medical Journal53, 308–310.
19.
References originally found in WainwrightM. (1993). The mystery of the plate: Fleming's discovery and contribution to the early development of penicillin. Journal of Medical Biography1, 59–65; Hare Archive: Letter from Dolman to Hare 6 Dec 1955; Letter from Rogers to Hare 29 Dec 1955; Letter from Craddock to Hare 12 June 1955; Swain H.T. (1992). Medicine in Sheffield. Quarterly Journal of Medicine 296, 1041–1049; and Diggins, F.E.W. (1999). The true history of the discovery of penicillin, with refutation of the misinformation in the literature. British Journal of Biomedical Science 56, 83–93.
20.
HendersonJ.W. (1997). The yellow brick road to penicillin: a story of serendipity. Mayo Clinic Proceedings72, 683–687.
